Setting Standards for Proactive Pharmacovigilance in India

Add bookmark
Andrea Charles
Andrea Charles
03/17/2011

With more clinical research being conducted India, there is growing pressure to address pharmacovigilance concerns. Dr. Seema Rajsingh, Head- Pharmacovigilance at Biocon, joins Andrea Charles from Pharma IQ, to discuss the main challenges the industry currently faces, setting the standards for proactive pharmacovigilance in India and the strategies Indian pharmaceutical companies are employing to optimise their drug safety teams and pharmacovigilance activities. [inlinead]
To continue reading this story get free access

RECOMMENDED